US industry welcomes Supreme Court decision on process patents
This article was originally published in SRA
The US Supreme Court has ruled that the so-called "machine-or-transformation" test is not the only way to determine the patentability of a new method1. The test required a patentable process to be either tied to a machine or apparatus or to involve a transformation of an article into a different state or thing.
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.